Their recent struggles may soon give way to rising market interest and more lucrative returns.
News & Analysis: Supernus Pharmaceuticals
SUPN earnings call for the period ending December 31, 2020.
The company announced positive results from a clinical trial.
SUPN earnings call for the period ending September 30, 2020.
These stocks are just temporarily inconvenienced large caps in the making.
These two biotechs have the potential to become giants within their domains.
SUPN earnings call for the period ending June 30, 2020.
SUPN earnings call for the period ending March 31, 2020.
These two underrated biotech stocks have the potential to soar.
Shares slumped after the commercial-stage biopharma reported mixed results.